Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Vaccination with an Ovalbumin/Interleukin-4 Fusion DNA Efficiently Induces Th2 Cell-Mediated Immune Responses in an Ovalbumin-Specific Manner

  • Lim, Young-Shin (College of Pharmacy, Chonnam National University) ;
  • Kang, Bok-Yun (College of Pharmacy, Chonnam National University) ;
  • Kim, Eui-Jin (College of Pharmacy, Chonnam National University) ;
  • Kim, Seung-Hyun (College of Pharmacy, Chonnam National University) ;
  • Hwang, Seung-Yong (Department of biochemistry and Molecular Biology, Hanyang University) ;
  • Kim, Kyeong-Man (College of Pharmacy, chonnam National University) ;
  • Kim, Tae-Sung (College of Pharmacy, Institute of Biotechnology, Chonnam National University)
  • Published : 1998.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

to more effectively drive immune responses toward antigen-specific T helper type 2 (Th2) cell-mediated responses, we constructed a mammalian expression vetor (oPVA/IL4) carrying a fused gene in which the ovalbumin (OVA) cDNA was covalently linked to murine interleukin-4 (IL-4) cDNA. A biologically active OVA/IL4 DNA, as demonstrated by Wes tern blotting and cytokine bioassay. In tramuscular injection of BALB/c mice with the pOVA/IL4 DNA increased both the production of OVA-specific IL-4 by CD$4^{+}$ T cells and the ratio of anti-OVA lgG1 to anti-OVA lgG2a isotypes, while the injection with the pOVA DNA alone, or with the mixture of the pOVA and pIL4 DNA did no or little increase. furthermore, the OVA-specific, Th2 cell-mediated immune responses were significantly enhanced by multiple injections with the pOVA/IL4 DNA. These studies indicate that the direct linkage of an OVA gene to an IL-4 gene in the expression plasmid confines the effects of IL-4 to the OVA-specific cells, efficiently driving the immune response toward OVA-specific, Th2 cell-mediated responses.

Keywords

References

  1. Current Protools in Immunology Colligan;J.E.;Kruisbeek;A.M.;Margulies;D.H.;Shevvch;E.M.;Strober;W.
  2. Annu. Rev. Immunol. v.15 Induction of Th1 and Th2 CD4+ T Cell responses:the alterntive approaches Constant;S.L.;Bottomly;K.
  3. Vaccine v.12 Direct gene trasfer into muscle Danko;I.;Wolff;J.A.
  4. J. Immunol. v.154 IL-12 inhibits IL-4 synthesis in keyhole limpet hemocyanin-primed CD4 T ce;;s through an effect on abtigen-presenting cells DeKruyff;R.H.;Fang;Y.;Wolf;S.F.;Umetsu;D.T.
  5. Semin. Oncol. v.23 Immunotherapy of cancer with genetically modified tumor vaccines Gilboa;E.
  6. Bioconj. Chem. v.4 Biological activity and in vivo clerance of antitumor antibody/cytokine fusion proteins Gillies;S.D.;Young;D.;Lo;K.M.;Roberts;S.
  7. J. Immunol. v.150 Anti-IL-4 diminishes in vivo priming for antigen-specific IL-4 production by T cells Gross;A.;Ben-Sasson;Z.;Paul;W.E.
  8. J. Immunol. v.158 An ovalbumin-IL-12fusion protein is more effective than ovalbumim plus recombinant IL-12 in inducing a T Helper cell type 1-donimated immune responses and inhibiting antigen-specific IgE production Kim;T.S.;DeKruyff;R.H.;Rupper;R.;Maecker;H.T.;Levy;S.;Umetsu;D.T.
  9. Immunol. v.94 Potentiation of antigen-specific;Th1 immune responses by multiple DNA vaccination with an ovalbumin/interferon-γ hybrid construct Lim;Y.S.;Kang;B.Y.;Kim;E.J.;Kim;S.H.;Hwang;WS.Y.;Kim;T.S.
  10. Immunol. Rev. v.123 Diversity of cytokine synthesis and function of mouse CD4 T cells Mosmann;T.R.;Schumacher;J.H.;Street;N.F.;Budd;R.;O'Garra;A.;Fong;T.A.;Bond;M.W.;Moore;K.W.;Sher;A.;Fiorentino;D.F.
  11. J. Exp. Med. v.182 Heterogenicity of intracellular cytokine syvthesis at the single cell level in polarized T helper 1 and helper 2 populations Openshaw;P.;Murphy;E.Hosken;N.A.;Maino;Y.;Davis;K.;Murphy;K.;O'Garra;A.
  12. J. Virol. v.70 Influenza virus nucleoprotein-specific immuniglobulin G subclass and cytokine responses elicted by DNA vaccinationare dependent on the route of vector DNA delivery Pertmer;T.M.;Roberts;T.R.;Haynes;J.R.
  13. Blood v.83 Depletion of B cells in vivo by chimeric mouse human monoclonal antibody to CD20 Reff;M.E.;Garner;K.;Chambers;K.S.;Chinn;P.C.;Leonard;J.E.;Raab;R.;Newman;R.A.;Hanna;N.;Anderson;D.R.
  14. Clin. Immunol. Immunopathol. v.80 Th1 and Th2 in human disease Romagnani;S.
  15. Int. J. Clin. Res. v.26 Development of Th1- or Th2-dominated immune responses:what about the polarizing signals? Romagnani;S.
  16. Int. Arch. Allergy. Immunol. v.113 An update on human Th1 and Th2 cells Romagnari;S.;Parronchi;P.;D'Elio;M.M.;Romagniani;Sampognaro;S.;Mavilia;C.;De Carli;M.;Maggi;E.;Del Prete;G.F.
  17. Proc. Natl. Acad. Sci. USA v.90 Gene inoculation generates immune responses against human immunodrficiency virus type 1 Wang;B.;Ugen;K.E.;Srikantan;V.;Agadianyan;M.G.;Dang;K.;Refaeli;Y.;Sato;A.I.;Boyrt;J.';Williams;W.V.;Weiner;D.B.
  18. FFBS Lett. v.332 Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscle Wells;D.J.
  19. Ann. NY Acad. Sci. v.797 Proteins expressed by DNA vaccines induce both local and systemic immune responses Whitton;J.L.;Yokoyama;M.
  20. Science v.247 Direct gene trabsfer into mouse muscle in vivo Wolff;J.A.;Malone;R.W.;Williams;P.;Chong;W.;Acsaoi;G.;Jabi;A.;Felgner;P.L.
  21. Vaccine v.15 DNA immunization can stimulate florid local inflammation;and the antiviral immunity induced varies depending on injection site Yokoyama;M.;Hassett;D.E.;Zhang;J.;Whitton;J.L.;